Table 2 Application of the proposed and comparison methods to the determination of the studied drugs in pure forms
Parameter | proposed method | Comparison method(35) | ||
|---|---|---|---|---|
Conc.taken (μg/mL) | Conc.found (μg/mL) | % Founda | % Founda | |
PPA | 2.0 | 1.96 | 98.00 | |
4.0 | 4.01 | 100.25 | 99.53 | |
6.0 | 5.97 | 99.50 | 102.01 | |
10.0 | 10.07 | 100.70 | 100.11 | |
12.0 | 12.13 | 101.08 | ||
18.0 | 17.81 | 98.94 | ||
20.0 | 20.07 | 100.35 | ||
± S.D. | 99.83 ± 1.08 | 100.55± 1.29 | ||
t | 0.339 (2.306) | |||
F | 1.426 (5.14) | |||
Parameter | proposed method | Comparison Method (36) | ||
Conc. taken (μg/mL) | Conc. found (μg/mL) | % Found a | % Found a | |
EPH | 1.0 | 1.02 | 102.00 | |
3.0 | 2.98 | 99.33 | ||
5.0 | 5.02 | 100.40 | 102.00 | |
7.0 | 6.94 | 99.14 | 99.98 | |
8.0 | 7.98 | 99.75 | 101.05 | |
9.0 | 9.10 | 101.11 | ||
10.0 | 9.98 | 99.80 | ||
14.0 | 13.99 | 99.93 | ||
± S.D. | 100.18 ± 0.96 | 100.01 ± 1.01 | ||
t | 1.264 (2.262) | |||
F | 1.106 (4.74) | |||
Parameter | proposed method | Comparison Method (37) | ||
Conc. taken (μg/mL) | Conc. found (μg/mL) | % Found a | % Found a | |
PSE | 1.0 | 1.01 | 101.00 | 102.00 |
3.0 | 3.00 | 100.00 | 98.33 | |
4.0 | 3.94 | 98.50 | 98.01 | |
10.0 | 10.06 | 100.60 | ||
12.0 | 12.10 | 100.83 | ||
14.0 | 13.89 | 99.21 | ||
± S.D. | 100.02 ± 0.99 | 99.45 ± 2.22 | ||
t | 0.597 (2.365) | |||
F | 5.028 (5.79) | |||